Sinopharm Group Co. Ltd. (SHTDY)
- Previous Close
12.67 - Open
13.36 - Bid --
- Ask --
- Day's Range
13.35 - 13.49 - 52 Week Range
11.35 - 18.01 - Volume
5,675 - Avg. Volume
11,900 - Market Cap (intraday)
8.403B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
6.60 - EPS (TTM)
2.04 - Earnings Date --
- Forward Dividend & Yield 0.57 (4.27%)
- Ex-Dividend Date Jun 15, 2023
- 1y Target Est
--
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
www.sinopharmgroup.com.cn115,959
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SHTDY
Performance Overview: SHTDY
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHTDY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHTDY
Valuation Measures
Market Cap
8.37B
Enterprise Value
9.74B
Trailing P/E
6.60
Forward P/E
6.30
PEG Ratio (5yr expected)
2.36
Price/Sales (ttm)
0.10
Price/Book (mrq)
0.80
Enterprise Value/Revenue
0.02
Enterprise Value/EBITDA
0.43
Financial Highlights
Profitability and Income Statement
Profit Margin
1.52%
Return on Assets (ttm)
3.73%
Return on Equity (ttm)
13.03%
Revenue (ttm)
596.57B
Net Income Avi to Common (ttm)
9.05B
Diluted EPS (ttm)
2.04
Balance Sheet and Cash Flow
Total Cash (mrq)
63.81B
Total Debt/Equity (mrq)
61.32%
Levered Free Cash Flow (ttm)
6.64B
Company Insights: SHTDY
SHTDY does not have Company Insights